Vital Chemtech

₹82.9 0 | 0%

WEBSITE BSE:0 NSE : 17 May, 00:00

Market Cap ₹198 Cr.

Stock P/E 0.0

P/B 2.2

Current Price ₹82.9

Book Value ₹ 37.4

Face Value 10

52W High ₹127.9

Dividend Yield 0.6%

52W Low ₹ 67.1

Edit Ratio

Vital Chemtech Research see more...

Overview Inc. Year: 2013Industry: Chemicals

Vital Chemtech Limited is a leading manufacturer of phosphorus-based chemicals for various industries such as lifesciences, crop care, specialty chemicals, textile auxiliaries, dyes, pigments and plastic additives. It was founded in 1993 by Mr. Vipul Jatashanker Bhatt and Mrs. Sangeeta Vipul Bhatt, who are the promoters and directors of the company. The company has a state-of-the-art, integrated manufacturing complex in PCPIR region of Dahej, Gujarat, with PLC and SCADA operated systems and ZLD (Zero Liquid Discharge) facility to ensure minimum emissions and waste generation. The company is certified with ISO 9001:2015, ISO 45001:2018 and ISO 14001:2015 from Bureau Veritas to maintain highest quality, environmental and safety practices. The company produces Phosphorus Trichloride (PCl3), Phosphorus Oxychloride (POCl3), Phosphorus Pentachloride (PCl5), Phosphorus Pentoxide (P2O5), Poly Phosphoric Acid (PPA) and Phosphorus Pentasulfide (P2S5) for its customers across India and abroad.

Vital Chemtech Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Vital Chemtech Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Vital Chemtech Profit & Loss

#(Fig in Cr.)	Mar 2022	Mar 2023
Net Sales	58	117
Other Income	0	1
Total Income	58	118
Total Expenditure	46	103
Operating Profit	12	15
Interest	0	1
Depreciation	1	2
Exceptional Income / Expenses	0	0
Profit Before Tax	11	11
Provision for Tax	3	3
Profit After Tax	8	8
Adjustments	0	0
Profit After Adjustments	8	8
Adjusted Earnings Per Share	4.7	3.4

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	102%	0%	0%	0%
Operating Profit CAGR	25%	0%	0%	0%
PAT CAGR	0%	0%	0%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	-11%	NA%	NA%	NA%
ROE Average	15%	35%	35%	35%
ROCE Average	15%	18%	18%	18%

Vital Chemtech Balance Sheet

#(Fig in Cr.)	Mar 2022	Mar 2023
Shareholder's Funds	15	90
Minority's Interest	0	0
Borrowings	21	22
Other Non-Current Liabilities	0	0
Total Current Liabilities	45	25
Total Liabilities	81	138
Fixed Assets	17	21
Other Non-Current Assets	3	24
Total Current Assets	61	93
Total Assets	81	138

Vital Chemtech Cash Flow

#(Fig in Cr.)	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	0	6
Cash Flow from Operating Activities	-13	-8
Cash Flow from Investing Activities	1	-26
Cash Flow from Financing Activities	18	58
Net Cash Inflow / Outflow	6	24
Closing Cash & Cash Equivalent	6	31

Vital Chemtech Ratios

#	Mar 2022	Mar 2023
Earnings Per Share (Rs)	4.7	3.36
CEPS(Rs)	5.12	4.33
DPS(Rs)	0	0.5
Book NAV/Share(Rs)	8.7	37.41
Core EBITDA Margin(%)	20	12.02
EBIT Margin(%)	19.24	10.8
Pre Tax Margin(%)	18.39	9.84
PAT Margin (%)	13.71	6.9
Cash Profit Margin (%)	14.92	8.88
ROA(%)	9.72	7.35
ROE(%)	54.03	15.45
ROCE(%)	21.75	14.89
Receivable days	264.37	125.02
Inventory Days	57.36	35.21
Payable days	264.94	90.83
PER(x)	0	22.86
Price/Book(x)	0	2.05
Dividend Yield(%)	0	0.65
EV/Net Sales(x)	0.64	1.56
EV/Core EBITDA(x)	3.13	12.22
Net Sales Growth(%)	0	102.63
EBIT Growth(%)	0	13.77
PAT Growth(%)	0	1.94
EPS Growth(%)	0	-28.49
Debt/Equity(x)	2.49	0.32
Current Ratio(x)	1.34	3.66
Quick Ratio(x)	1.14	3.13
Interest Cover(x)	22.89	11.22
Total Debt/Mcap(x)	0	0.16

Vital Chemtech Shareholding Pattern

#	Mar 2023	Sep 2023	Mar 2024
Promoter	73.43	73.43	73.43
FII	3.62	0.78	0.56
DII	1.48	0.63	0
Public	21.47	25.16	26.01
Others	0	0	0
Total	100	100	100

#	Mar 2023	Sep 2023	Mar 2024
Promoter	1.76	1.76	1.76
FII	0.09	0.02	0.01
DII	0.04	0.02	0
Public	0.51	0.6	0.62
Others	0	0	0
Total	2.4	2.4	2.4

Pros

Company has a good return on equity (ROE) track record: 3 Years ROE 35%
Debtor days have improved from 264.94 to 90.83days.
Company is almost debt free.

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.